In the past decade, some clinical studies suggested that blocking VEGF might be harmful to retinal vascular integrity, especially in patients with preexisting retinal ischemia; in these patients, anti-VEGF therapy aggravated retinal ischemia because retinal nonperfusion (RNP) areas enlarged after anti-VEGF therapy [5, 6]. This evidence concerns the gene VEGFA and retinal ischemia.